ReviewInternational journal of nanomedicine2007

Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator).

Usha Panchapakesan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.